Skip to main content
    G

    GE HealthCare Technologies Inc. (GEHC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $82.96
    -0.06 (-0.07%)

    Market Cap: $37.54B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    GE HealthCare Technologies Inc. (GEHC) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to GE HealthCare Technologies are DexCom (DXCM), Koninklijke Philips NV ADR (PHG) and STERIS (STE). GE HealthCare Technologies trades at 16.9x earnings, against a median of 21.9x for the 11 of these companies with a P/E. By market cap, GE HealthCare Technologies ranks 5th of the 13 companies on this page; Abbott Laboratories (ABT) is the largest at $187.95B.

    Peer Comparison

    GEHC's ROIC of 11.9% is above the peer median of 7.5%, and its revenue growth of 7.2% is below the median of 9.9%. It yields 0.19%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    GE HealthCare Technologies (GEHC)$37.54B16.9x1.7x9.9%11.9%7.2%0.19%
    DexCom Inc (DXCM)$31.08B30.6x6.0x19.4%26.2%11.2%0.00%
    Koninklijke Philips NV ADR (PHG)$29.66BN/A1.5x5.4%7.2%2.1%3.34%
    STERIS plc (STE)$25.67B24.1x4.1x13.4%9.4%8.8%1.05%
    Edwards Lifesciences Corp (EW)$61.61B36.4x9.2x15.3%7.5%10.5%0.00%
    Zimmer Biomet Holdings Inc (ZBH)$19.53B12.0x2.3x8.9%5.0%3.1%0.95%
    Boston Scientific Corp (BSX)$64.27B13.7x3.0x16.6%10.2%1.4%0.00%
    Medtronic PLC (MDT)$131.57B18.0x3.5x13.9%7.5%13.7%2.80%
    Globus Medical (GMED)$9.57B14.2x3.0x17.8%N/A-0.7%0.00%
    Penumbra Inc (PEN)$12.65B77.4x8.1x10.1%N/A15.6%0.00%
    Abbott Laboratories (ABT)$187.95B20.0x3.9x9.8%6.3%14.5%2.34%
    Haemonetics Corporation (HAE)$5.60B23.9x4.0x7.5%5.1%9.3%0.00%
    Insulet Corporation (PODD)$10.58B21.9x3.2x13.4%18.1%19.2%0.00%
    Peer median$27.66B21.9x3.7x13.4%7.5%9.9%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to GE HealthCare Technologies, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    DexCom Inc (DXCM)
    DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management.
    DXCM competitors
    Koninklijke Philips NV ADR (PHG)
    Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally.
    PHG competitors
    STERIS plc (STE)
    Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system.
    STE competitors
    Edwards Lifesciences Corp (EW)
    Edwards Lifesciences is an American medical technology company headquartered in Irvine, California...
    EW competitors
    Zimmer Biomet Holdings Inc (ZBH)
    Zimmer Biomet is a publicly traded medical device company.
    ZBH competitors
    Boston Scientific Corp (BSX)
    Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties...
    BSX competitors
    Medtronic PLC (MDT)
    Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States.
    MDT competitors
    Globus Medical (GMED)
    Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders.
    GMED competitors
    Penumbra Inc (PEN)
    Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally.
    PEN competitors
    Abbott Laboratories (ABT)
    Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
    ABT competitors
    Haemonetics Corporation (HAE)
    Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
    HAE competitors
    Insulet Corporation (PODD)
    Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
    PODD competitors

    Frequently Asked Questions About GEHC

    Who are GE HealthCare Technologies' main competitors?

    The companies most similar to GE HealthCare Technologies include DexCom (DXCM), Koninklijke Philips NV ADR (PHG), STERIS (STE), Edwards Lifesciences (EW) and Zimmer Biomet Holdings (ZBH), listed from the closest match.

    Who is GE HealthCare Technologies' biggest competitor?

    Abbott Laboratories (ABT) is the largest of the similar companies at $187.95B; DexCom (DXCM) is the closest match by business profile, size, sector and industry.

    How does GEHC stock compare with its competitors?

    GEHC's P/E is 16.9x against a peer median of 21.9x; its P/S is 1.7x against a peer median of 3.7x; its net margin is 9.9% against a peer median of 13.4%.

    Which of GE HealthCare Technologies' competitors pays a higher dividend?

    GE HealthCare Technologies has a forward dividend yield of 0.19%. Koninklijke Philips NV ADR (PHG), Medtronic (MDT), Abbott Laboratories (ABT), STERIS (STE) and Zimmer Biomet Holdings (ZBH) have higher forward dividend yields; Koninklijke Philips NV ADR (PHG) has the highest at 3.34%.

    Is GE HealthCare Technologies bigger than its competitors?

    No. GE HealthCare Technologies is 5th by market cap among the 13 companies on this page; the largest is Abbott Laboratories (ABT) at $187.95B.